Thomson Reuters, 4301 Connecticut Avenue NW, Suite 330, Washington, DC 20008, USA.
J Occup Environ Med. 2010 Feb;52(2):125-30. doi: 10.1097/JOM.0b013e3181ce10a8.
Estimate the productivity-related cost of depression in an employed population.
By using administrative data, annual short-term disability (STD) and absenteeism costs ($2005) were compared for patients with depression and treated with antidepressants and for a matched control group without depression.
Mean annual STD costs were $1038 among treated depressed patients versus $325 among controls and $1685 among a subgroup of severely depressed treated patients versus $340 among their controls. After controlling for demographic and employment characteristics, treated patients with depression had STD costs that were $356 higher per patient and those with severe depression had costs that were $861 higher. The marginal impact of treated depression on absenteeism was $377.
Even when depressed patients are treated with antidepressants, there are substantial productivity losses. Therapies that can better manage depression may provide opportunities for savings to employers.
估算在职人群中抑郁症相关的生产力成本。
通过使用行政数据，比较了患有抑郁症并接受抗抑郁药物治疗的患者与未患抑郁症且匹配对照组的年度短期残疾（STD）和旷工成本（2005 年美元）。
治疗组中抑郁患者的平均年 STD 成本为 1038 美元，而对照组为 325 美元，重度抑郁治疗组为 1685 美元，而对照组为 340 美元。在控制了人口统计学和就业特征后，患有抑郁症的治疗患者的 STD 成本每人高出 356 美元，而患有严重抑郁症的患者的成本每人高出 861 美元。治疗抑郁症对旷工的边际影响为 377 美元。
即使对抑郁患者进行了抗抑郁药物治疗，仍会导致大量生产力损失。能够更好地管理抑郁症的疗法可能为雇主节省成本提供机会。
